510(k) Report

510(k) · Cleared

Cleared

BioZorb SP Marker

K192371510(k) SpecialCleared Sep 26, 201927-day reviewClass II21 CFR 878.4300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Focal Therapeutics · NEU Marker, Radiographic, Implantable

Cleared on Sep 26, 2019 as substantially equivalent to K143484 (Focal Therapeutics, 2015) and 1 other predicate after a 27-day review. Its family tree reaches back 7 generations to 2001. 2 of the 15 devices in its family, counting itself, have a Class I recall.

Decided
Sep 26, 2019
Review
27 days
Class
Class II
Product code
NEU
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K001807 (2001). 14 ancestors in all. No later device cites it as a predicate yet. 2 of the 15 devices in this family, counting this one, have a Class I recall.

  1. Root · 7 generations backK001807 Tissue MarkerAdvanced Uroscience, Inc. · 2001
  2. 6 generations backK032347 Biomarc Tissue MarkerCarbon Medical Technologies, Inc. · 2003
  3. 5 generations backK042296 Biomarc Preloaded Tissue Marker DeviceCarbon Medical Technologies, Inc. · 2004
  4. 4 generations backK072913 Securmark Biopsy Site Identification SystemSuros Surgical Systems, Inc. A Hologic Company · 2008
  5. 3 generations backK113202 Tissue MarkerFocal Therapeutics · 2012
  6. 2 generations backK143484 BioZorb MarkerFocal Therapeutics · 2015 · Recalled (Class I)
  7. 1 generation backK152070 BioZorb LP MarkerFocal Therapeutics · 2015 · Recalled (Class I)
  8. This deviceK192371 BioZorb SP MarkerFocal Therapeutics · 2019

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K001807Tissue MarkerAdvanced Uroscience, Inc.2001—
−6K032347Biomarc Tissue MarkerCarbon Medical Technologies, Inc.2003—
−5K042296Biomarc Preloaded Tissue Marker DeviceCarbon Medical Technologies, Inc.2004—
−4K072913Securmark Biopsy Site Identification SystemSuros Surgical Systems, Inc. A Hologic Company2008—
−3K113202Tissue MarkerFocal Therapeutics2012—
−2K143484BioZorb MarkerFocal Therapeutics2015Class I
−1K152070BioZorb LP MarkerFocal Therapeutics2015Class I
0 (this device)K192371BioZorb SP MarkerFocal Therapeutics2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200210
200310
200720
201010
201110
FIG. 1 — Lineage of K192371, 2001–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NEU device

  1. #1 K240042 MOLLI 2 Systemscore 14.4 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K143484BioZorb Marker
Summary page 4
…Product Code: NEU Classification: Class II Panel: General and Plastic Surgery III. PREDICATE DEVICE BioZorb Marker (K143484) BioZorb LP Marker (K152070) These cleared products have not been subject to a design-related recall.…
Focal Therapeutics2015Class I
*K152070BioZorb LP Marker
Summary page 4
…lassification: Class II Panel: General and Plastic Surgery III. PREDICATE DEVICE BioZorb Marker (K143484) BioZorb LP Marker (K152070) These cleared products have not been subject to a design-related recall. IV. DEVICE DESCRIPTION…
Focal Therapeutics2015Class I

Also cleared against K143484: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (2 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K152070BioZorb LP MarkerFocal Therapeutics · 2015 · Direct predicate · ◆ on the line of descent in FIG. 12 Class I recalls
  • K143484BioZorb MarkerFocal Therapeutics · 2015 · Direct predicate · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 3.3 years on median.
  • 3 of the 14 ancestors have a recall of any class; 2 have a Class I recall.
  • 4 other devices also cite its predicate K143484.

How does its category compare?

All NEU devices

NEU Marker, Radiographic, Implantable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · NEU

5in 2025

2007: 42008: 72009: 42010: 52011: 32012: 32013: 72014: 32015: 72016: 22017: 42018: 82019: 52020: 32021: 32022: 22023: 42024: 102025: 52026 (partial year): 1
2007high 10 (2024) · low 2 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NEU

99in 2025

2007: 94 days median2008: 107 days median2009: 70 days median2010: 69 days median2011: 145 days median2012: 120 days median2013: 49 days median2014: 48 days median2015: 111 days median2017: 115 days median2018: 89 days median2019: 149 days median2020: 169 days median2021: 46 days median2023: 136 days median2024: 267 days median2025: 99 days median
2007high 267 (2024) · low 46 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NEU

2in 2025

2011: 12017: 12022: 12024: 2, 1 Class I2025: 22026 (partial year): 2
2007high 2 (2024) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · NEU

411in 2025

2007: 52008: 52009: 302010: 122011: 182012: 542013: 602014: 382015: 1202016: 562017: 692018: 662019: 582020: 452021: 822022: 1002023: 1422024: 2472025: 411
2007high 411 (2025) · low 5 (2007)2025

MAUDE reports naming product code NEU, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200749405
2008710705
2009470030
2010569012
20113145118
20123120054
2013749060
2014348038
201571110120
20162—056
20174115169
2018889066
20195149058
20203169045
2021346082
20222—1100
202341360142
2024102672 (1)247
20255992411
20261—2—

What is it indicated for?

The BioZorb SP Marker is indicated for radiographic marking of sites in soft tissue. In addition, the Marker is indicated in situations where the soft tissue site needs to be marked for future medical procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K192371: BioZorb SP Marker.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K192371

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026